In this video Naresh Gunaratnam, MD, discusses the gastroenterology fellowship program that Huron Gastroenterology developed with Trinity Health in Ann Arbor, Mich. Dr. Gunaratnam helped create the program because he and his colleagues felt that traditional fellowship programs don’t always provide information or guidance about non-academic career pathways in gastroenterology. Hear from Dr. Gunaratnam how the fellowship program at Huron Gastroenterology is training fellows to become excellent clinicians who care for patients in the community setting. He has no financial conflicts relative to the topics in this video.
Author: Abhay Panchal
“They all laughed when I spoke of greedy doctors.”Spoken by Dr Ralph Crawshaw at the Oregon Medical Association, as documented in the Western Journal of Medicine.Crawshaw continued: …the central clinical problem we physicians face in clinical practice is appetite control. Patients seem insatiably hungry for cigarettes, food, sex, money, love and pills. Are we so different from our patients? My good friend Ralph was a leader in the development of the Oregon Health Plan. He also proposed that the Impaired Physician Program of the Oregon Medical Association look into physicians who were “impaired by money.”
Colorectal cancer (CRC) remains the second most common cause of cancer-related death in the United States. Although the past several decades have seen significantly greater emphasis on screening and disease prevention for CRC, it has also become increasingly apparent that the age profile and associated risks for this cancer are rapidly changing. Evidence of this can be found in recently released CRC statistics from the American Cancer Society, which are updated every 3 years using population-based cancer registries. The incidence in CRC has shown a progressive decline over the past four decades. However, whereas in the 2000s there was an…
It’s been over 2 decades since 37-year-old Joshua Denton was diagnosed with ulcerative colitis. Controlling the physical symptoms of comorbidities, such as inflammatory bowel disease, have been possible, but he was surprised when depression and anxiety set in. “You’re dealing with what I call the anxiety of the unknown. What does this mean?” said Mr. Denton, who serves as a patient advocate with Color of Crohn’s & Chronic Illness, a nonprofit group aimed at improving quality of life for racial-ethnic minorities. “When you understand that it’s autoimmune that is chronic and incurable, you’re wondering, ‘Am I going to have a…
With shifting consumer demands for fast and convenient services, healthcare organizations are embracing digital transformation. In turn, the Big Tech companies are accelerating their pursuit of the healthcare market. They are leveraging their vast resources and data insights to develop innovative solutions that could change the game for both consumers and medical professionals alike. Below, I break down how these tech giants are working to reshape healthcare with new initiatives, products, and investments. Big tech companies are increasing their investments in healthcare. In 2021, Apple, Alphabet (Google), Amazon, Microsoft, and Meta collectively invested over $3.1 billion in the healthcare industry,…
UnitedHealth Group has quietly added yet another provider group to its growing Optum Health subsidiary. Earlier this year, UHG acquired Crystal Run Healthcare, a New York-based physician group with about 400 doctors. There was no fanfare around the acquisition until media reports resurfaced it this week. Local newspaper Mid-Hudson News obtained an internal email in late February, where Crystal Run leaders informed employees that they were a part of Optum as of Feb. 22. In the message, CEO Hal Teitelbaum, M.D., said the deal would advance the provider group’s value-based care capabilities.
Editor’s note: This story has been updated with additional information from a filing with the Securities and Exchange Commission. Pear Therapeutics, maker of prescription digital therapeutics, announced today that it has filed for Chapter 11 bankruptcy and is seeking a sale of its business or assets. The company will continue its scaled-down operations during Chapter 11 as it seeks a sale, and Pear will use its available cash to fund its operations and costs post-petition. The Boston-based company’s CEO Corey McCann referenced the filing on LinkedIn, stating, “Today is a difficult day for Pear Therapeutics. We announced that Pear voluntarily…
Precision diagnostics company Oncocyte on Friday announced the publication of results from the randomized phase II AtezoTRIBE clinical trial for metastatic colorectal cancer (mCRC), which used the company’s DetermaIO gene-expression test. The results, published in Clinical Cancer Research, show that DetermaIO, which assesses the tumor microenvironment to predict response to immune checkpoint inhibitor (ICI) treatment, identified more patients who were potentially responsive to ICI treatment than current biomarkers.
The physician-led Independent Physician Association of New York, one of the largest in the nation, has been acquired by the private equity-backed Vytalize Health, through an investment in Practice Management of America. An announcement from Vytalize states that the deal builds on an existing partnership between the organizations dating to 2020 and accelerates the firm’s expansion into Medicare Advantage, commercial plans, Medicaid, and multi-specialty care. “IPA NY is a longtime partner that shares our commitment to supporting independent physicians and helping them succeed in delivering high-quality, value-based care,” said Faris Ghawi, Vytalize Health co-founder and CEO, in a statement.
Key takeaways: Patients with rectal cancer who were observed by a watch-and-wait approach reported “good” quality of life and less major bowel dysfunction than those requiring surgery, according to study results in JAMA Surgery.